Abbott Laboratories (NYSE:ABT)

BATS BZX Real-Time Price
As of 3:18pm ET
 +0.62 / +0.87%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Contact Information

Abbott Laboratories
100 Abbott Park Road
Abbott Park Illinois 60064-6400
P:(224) 667-6100
Investor Relations:



Mutual fund holders41.41%
Individual stakeholders4.12%
Other institutional33.53%

Top Executives

Miles D. WhiteChairman & Chief Executive Officer
Brian Bernard YoorChief Financial Officer & Executive VP-Finance
James E. YoungChief Compliance & Ethics Officer, Vice President
Hubert L. AllenSecretary, Executive VP & General Counsel
Robert E. FunckPrincipal Accounting Officer, SVP & Controller